The Fluorescent Cell Line SW620-GFP Is a Valuable Model to Monitor Magnetic Hyperthermia.
Saray RosalesRodolfo Hernández GutiérrezAlma OaxacaZaira LópezNorberto CasillasPeter KnauthLuis H QuinteroJosé A PazFrancisco CholicoCelso VelásquezMario E CanoPublished in: Bioengineering (Basel, Switzerland) (2024)
In this work, the cell line SW620-GFP has been used in a complete magnetic hyperthermia assay, from the preparation of the ferrofluid with folate-coated iron oxide nanoparticles to in vivo experiments. The physical and chemical characterization of the nanoparticles evidenced their superparamagnetic behaviour, an average diameter of 12 ± 4 nm, a 2 nm coat thickness, and a high-power loss density. The main innovation of the work is the exclusive capability of viable SW620-GFP cells to emit fluorescence, enabling fast analysis of both, cell viability in vitro with an epifluorescence microscope and tumour size and shape in vivo in a non-invasive manner using the iBox technology. Moreover, with this imaging technique, it was possible to demonstrate the successful tumour size reduction in mice applying magnetic hyperthermia three times a week over 3 weeks.
Keyphrases
- iron oxide nanoparticles
- molecularly imprinted
- induced apoptosis
- photodynamic therapy
- solid phase extraction
- high resolution
- cell cycle arrest
- mental health
- high throughput
- physical activity
- type diabetes
- optical coherence tomography
- metabolic syndrome
- single molecule
- living cells
- oxidative stress
- endoplasmic reticulum stress
- fluorescence imaging
- high fat diet induced
- mass spectrometry
- randomized controlled trial
- optic nerve
- gestational age
- study protocol
- light emitting
- placebo controlled
- preterm birth
- tandem mass spectrometry